Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients.

BACKGROUND Delirium occurs in up to 80% of intensive care patients and is associated with poor outcomes. The biological cause of delirium remains elusive. OBJECTIVES To determine if delirium and recovery are associated with serum levels of interleukins and apolipoprotein E over time and with apolipoprotein E genotype. METHODS The sample consisted of 77 patients with no previous cognitive deficits who required mechanical ventilation for 24 to 96 hours. Daily serum samples were obtained for enzyme-linked immunosorbent assay measurements of interleukins 6, 8, and 10 and apolipoprotein E. DNA extracted from blood was analyzed for apolipoprotein E genotyping. The Confusion Assessment Method for the Intensive Care Unit was administered daily on days 2 through 9. RESULTS Among the 77 patients, 23% had no delirium, 46% experienced delirium, and 31% experienced coma. Additionally, 77% had delirium or coma (acute brain dysfunction), and compared with other patients, had fewer ventilator-free days (P = .03), longer stay (P = .04), higher care needs at discharge (P = .001), higher mortality (P = .02), and higher levels of interleukin 6 (P = .03), and the APOE*3/*3 apolipoprotein E genotype (P = .05). Serum levels of apolipoprotein E correlated with levels of interleukins 8 and 10. Patients with the E4 allele of apolipoprotein E had shorter duration of delirium (P = .02) and lower mortality (P = .03) than did patients without this allele. CONCLUSIONS Apolipoprotein E plays a complex role in illness response and recovery in critically ill patients. The relationship between apolipoprotein E genotype and brain dysfunction and survival is unclear.

[1]  D. Holtzman,et al.  Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.

[2]  J. Quevedo,et al.  Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis , 2011, Intensive Care Medicine.

[3]  E. Ely,et al.  Sedation, delirium and mechanical ventilation: the ‘ABCDE’ approach , 2011, Current opinion in critical care.

[4]  D. Needham,et al.  Long-term complications of critical care , 2011, Critical care medicine.

[5]  M. Taljaard,et al.  A prospective cohort study evaluating associations among delirium, postoperative cognitive dysfunction, and apolipoprotein E genotype following open aortic repair , 2011, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[6]  Lori A. Coburn,et al.  The Apolipoprotein E-Mimetic Peptide COG112 Inhibits NF-κB Signaling, Proinflammatory Cytokine Expression, and Disease Activity in Murine Models of Colitis* , 2010, The Journal of Biological Chemistry.

[7]  M. Vitek,et al.  Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an apolipoprotein E-based therapeutic. , 2010, Journal of neurotrauma.

[8]  J. Jia,et al.  The interleukin-6 gene −572C/G promoter polymorphism modifies Alzheimer's risk in APOE ɛ4 carriers , 2010, Neuroscience Letters.

[9]  P. Eikelenboom,et al.  Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. , 2010, JAMA.

[10]  A. Slooter,et al.  Delirium in Intensive Care Unit Patients , 2010, Seminars in cardiothoracic and vascular anesthesia.

[11]  G. Bernard,et al.  Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial* , 2010, Critical care medicine.

[12]  A. Zwinderman,et al.  The association between delirium and the apolipoprotein E epsilon 4 allele: new study results and a meta-analysis. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[13]  Carol A. Colton,et al.  APOE genotype-specific differences in the innate immune response , 2009, Neurobiology of Aging.

[14]  T. Cowie,et al.  The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery. , 2008, The Annals of thoracic surgery.

[15]  E. Marcantonio,et al.  Chemokines are associated with delirium after cardiac surgery. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  E. Corder,et al.  Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation , 2007, Neurobiology of Aging.

[17]  A. Zwinderman,et al.  The association between delirium and the apolipoprotein E ϵ4 allele in the elderly , 2007, Psychiatric genetics.

[18]  P. Kwok,et al.  Apolipoprotein E e4 Allele Increases the Risk of Early Postoperative Delirium in Older Patients Undergoing Noncardiac Surgery , 2007, Anesthesiology.

[19]  G. Hamilton,et al.  APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients , 2007, International journal of geriatric psychiatry.

[20]  M. Tsolaki,et al.  The Role of Apolipoprotein E in Cognitive Decline and Delirium after Bypass Heart Operations , 2007, American journal of Alzheimer's disease and other dementias.

[21]  S. Inouye,et al.  Delirium in older people , 2007, BMJ : British Medical Journal.

[22]  Y. Ho,et al.  Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF-alpha and IL-6 in macrophages. , 2007, Archives of biochemistry and biophysics.

[23]  P. Pandharipande,et al.  Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients* , 2007, Critical care medicine.

[24]  P. V. Van Ness,et al.  A research algorithm to improve detection of delirium in the intensive care unit , 2006, Critical care.

[25]  T. Montine,et al.  Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  S. Gottfried,et al.  Incidence, risk factors and consequences of ICU delirium , 2006, Intensive Care Medicine.

[27]  M. Vitek,et al.  A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.

[28]  R. Guerrant,et al.  APOE4 Protects the Cognitive Development in Children with Heavy Diarrhea Burdens in Northeast Brazil , 2005, Pediatric Research.

[29]  Joel Schwartz,et al.  Apolipoprotein E Genotype Predicts 24-Month Bayley Scales Infant Development Score , 2003, Pediatric Research.

[30]  J. Poirier.  Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. , 2003, Trends in molecular medicine.

[31]  C. Sessler,et al.  The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. , 2002, American journal of respiratory and critical care medicine.

[32]  G. Bernard,et al.  Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). , 2001, JAMA.

[33]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[34]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[35]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[36]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.